Pfizer (PFE)
(Delayed Data from NYSE)
$29.98 USD
+0.48 (1.63%)
Updated Jul 24, 2024 04:01 PM ET
After-Market: $29.93 -0.05 (-0.17%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Pfizer Inc. [PFE]
Reports for Purchase
Showing records 561 - 568 ( 568 total )
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Acquisition of Wyeth to ease pressure on topline.Earnings growth to bounce back to respectable levels in CY10, on back of effective cost cutting measures & Wyeth related merger synergies.
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
With Wyeth in the Fold, Pfizer is Looking Ahead to Merger Synergies and Life After Lipitor
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S